Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.

Limit to evidence status or GRADE (optional)

15,213 questions in 2,394 reviews

current versions
No studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Active vs passive information provision
All outcomes ‐ not measured · stroke survivors and their carers
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Active information provision vs control
Positive mental well‐being · stroke survivors
Information provision for stroke survivors and their carers (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Time to next course of antibiotics  · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Adverse events during treatment · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: single vs combination intravenous anti‐pseudomonal antibiotic therapy
Additional treatment required  · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: single vs combination intravenous anti‐pseudomonal antibiotic therapy
Time to next course of antibiotics  · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: single vs combination intravenous anti‐pseudomonal antibiotic therapy
Quality of life  · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Change in FEV1 (% predicted) · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Change in sputum P aeruginosa density at end of treatment (cfu/g) Â · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Summary of findings: Single vs combination intravenous anti‐pseudomonal antibiotic therapy
Additional treatment required  · children and adults with cystic fibrosis
Single versus combination intravenous anti‐pseudomonal antibiotic therapy for people with cystic fibrosis (2021) · Cochrane
no estimate extractedNRNo studies
Dietary advice vs oral nutritional supplements
Length of hospital stay (days) Â · adults with disease‐related malnutrition
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults (2021) · Cochrane
no estimate extractedNRNo studies
Dietary advice vs oral nutritional supplements
Complications  · adults with disease‐related malnutrition
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults (2021) · Cochrane
no estimate extractedNRNo studies
Dietary advice vs oral nutritional supplements
Change in fat‐free mass (kg) · adults with disease‐related malnutrition
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults (2021) · Cochrane
no estimate extractedNRNo studies
Dietary advice vs no advice
Number of people admitted or readmitted to hospital · adults with disease‐related malnutrition
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults (2021) · Cochrane
no estimate extractedNRNo studies
Dietary advice plus supplements vs no dietary advice plus no supplements
Number of people admitted or re‐admitted to hospital · adults with disease‐related malnutrition
Dietary advice with or without oral nutritional supplements for disease‐related malnutrition in adults (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs diazepam
Neonatal and infant mortality · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs diazepam
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs diazepam
Adverse events To discharge · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs chlorpromazine
Neonatal and infant mortality · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs chlorpromazine
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs chlorpromazine
Days' pharmacological treatment · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital and opioid vs opioid alone
Neonatal and infant mortality · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital and opioid vs opioid alone
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital and opioid vs opioid alone
Days' pharmacological treatment · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital and opioid vs opioid alone
Adverse events To discharge · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs supportive care
Neonatal and infant mortality · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Clonidine and opioid vs opioid alone
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Clonidine and opioid vs opioid alone
Days' hospitalisation · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Clonidine and opioid vs phenobarbital and opioid
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs supportive care
Neurodevelopmental disability · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs supportive care
Adverse events To discharge · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Phenobarbital vs diazepam
Seizures To discharge · newborn infants with opioid withdrawal
Sedatives for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs methadone
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs methadone
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs buprenorphine
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs buprenorphine
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs dilute tincture of opium
Treatment failure · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs dilute tincture of opium
Seizures · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs dilute tincture of opium
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs dilute tincture of opium
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Morphine vs dilute tincture of opium
Adverse events (treatment related) To discharge · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs placebo or no treatment / usual care
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs clonidine
Seizures · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs clonidine
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs clonidine
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs clonidine
Adverse events (treatment related) To discharge · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs diazepam
Seizures To discharge · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs diazepam
Neonatal or infant mortality · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs diazepam
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies
Opioid vs placebo or no treatment / usual care
Neurodevelopmental disability · newborn infants with opioid withdrawal
Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane
no estimate extractedNRNo studies